Publikationen von Michael Fichter

Wirsching, S.; Fichter, M.; Cacicedo, M. L.; Landfester, K.; Gehring, S.: Modification of Regulatory T Cell Epitopes Promotes Effector T Cell Responses to Aspartyl/Asparaginyl β-Hydroxylase. International Journal of Molecular Sciences 23 (20), 12444 (2022)

Wirsching, S.; Machtakova, M.; Borgans, F.; Pretsch, L.; Fichter, M.; Cacicedo, M. L.; Therien-Aubin, H.; Landfester, K.; Gehring, S.: OVA-PEG-R848 nanocapsules stimulate neonatal conventional and plasmacytoid dendritic cells. Frontiers in Pediatrics 10, 966113 (2022)

Brückner, M.; Fichter, M.; da Costa Marques, R.; Landfester, K.; Mailänder, V.: PEG Spacer Length Substantially Affects Antibody-Based Nanocarrier Targeting of Dendritic Cell Subsets. Pharmaceutics 14 (8), 1614 (2022)

Hüppe, N.; Schunke, J.; Fichter, M.; Mailaender, V.; Wurm, F.; Wurm, F.; Landfester, K.: Multicomponent encapsulation into fully degradable protein nanocarriers via interfacial azide-alkyne click reaction in miniemulsion allows the co-delivery of immunotherapeutics. Nanoscale Horizons 7 (8), S. 908 - 915 (2022)

Simon, J.; Fichter, M.; Kuhn, G.; Brückner, M.; Kappel, C.; Schunke, J.; Klaus, T.; Grabbe, S.; Landfester, K.; Mailänder, V.: Achieving dendritic cell subset-specific targeting in vivo by site-directed conjugation of targeting antibodies to nanocarriers. Nano Today 43, 101375 (2022)